UPLOAD Filing
Design Therapeutics, Inc.
Date: May 13, 2025 · CIK: 0001807120 · Accession: 0000000000-25-005100
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-287043
Letter
Re: Design Therapeutics, Inc. Registration Statement on Form S-3 Filed May 7, 2025 File No. 333-287043 Dear Pratik Shah:
May 13, 2025
Pratik Shah Chief Executive Officer Design Therapeutics, Inc. 6005 Hidden Valley Road, Suite 110 Carlsbad, CA 92011
This is to advise you that we have not reviewed and will not review your registration statement.
Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Please contact Jessica Dickerson at 202-551-8013 with any questions.
Sincerely,
Division of
Corporation Finance
Office of Life
Sciences
cc: Kenneth J. Rollins, Esq.
Show Raw Text
<DOCUMENT> <TYPE>TEXT-EXTRACT <SEQUENCE>2 <FILENAME>filename2.txt <TEXT> May 13, 2025 Pratik Shah Chief Executive Officer Design Therapeutics, Inc. 6005 Hidden Valley Road, Suite 110 Carlsbad, CA 92011 Re: Design Therapeutics, Inc. Registration Statement on Form S-3 Filed May 7, 2025 File No. 333-287043 Dear Pratik Shah: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Jessica Dickerson at 202-551-8013 with any questions. Sincerely, Division of Corporation Finance Office of Life Sciences cc: Kenneth J. Rollins, Esq. </TEXT> </DOCUMENT>